Pharmacia North America Rx President Is Spiers; Hassan Adds Chairman Title
Executive Summary
Pharmacia North American Pharmaceuticals President Mark Spiers will lead the company's search for a new head of U.S. sales.
You may also be interested in...
Merck Cozaar profit sharing
Dupont will receive 50% of Cozaar operating profits in North America starting Feb. 1, Merck Investor Relations Senior Director Laura Jordan announces Jan. 23. Existing Dupont royalties on Merck's losartan products Cozaar and Hyzaar will remain unchanged. Dupont receives 10% of profits from sales of the hypertension products. The profit sharing will give Dupont its largest source of revenue as the chemical company moves forward with plans to spin off the Rx business. Cozaar/Hyzaar revenues in the U.S. totaled $770 mil. in 2000
Novartis U.S. Rx Marketing Head Schofield Joins From Pharmacia
Novartis' efforts to reinvigorate its U.S. pharmaceuticals business in 2001 will be led by former Pharmacia VP-U.S. Sales Greg Schofield.
DuPont Spinning Off Rx Business As Cozaar Profit-Share Trigger Nears
DuPont's handling of the profit-sharing agreement for Cozaar is a central consideration in the valuing of the company's planned prescription drug spin-off.